| Literature DB >> 33924503 |
Andrés Ramírez-López1, María Teresa Álvarez Román1, Elena Monzón Manzano1, Paula Acuña1, Elena G Arias-Salgado1, Mónica Martín Salces1, María Isabel Rivas Pollmar1, Víctor Jiménez Yuste1,2, Raul Justo Sanz1, Sara García Barcenilla1, Tamara Cebanu1, Elena González Zorrilla1, Nora V Butta1.
Abstract
Loss of sialic acid from the carbohydrate side chains of platelet glycoproteins can affect platelet clearance, a proposed mechanism involved in the etiopathogenesis of immune thrombocytopaenia (ITP). We aimed to assess whether changes in platelet glycosylation in patients with ITP affected platelet counts, function, and apoptosis. This observational, prospective, and transversal study included 82 patients with chronic primary ITP and 115 healthy controls. We measured platelet activation markers and assayed platelet glycosylation and caspase activity, analysing samples using flow cytometry. Platelets from patients with ITP with a platelet count <30 × 103/µL presented less sialic acid. Levels of α1,6-fucose (a glycan residue that can directly regulate antibody-dependent cellular cytotoxicity) and α-mannose (which can be recognised by mannose-binding-lectin and activate the complement pathway) were increased in the platelets from these patients. Platelet surface exposure of other glycoside residues due to sialic acid loss inversely correlated with platelet count and the ability to be activated. Moreover, loss of sialic acid induced the ingestion of platelets by human hepatome HepG2 cells. Changes in glycoside composition of glycoproteins on the platelets' surface impaired their functional capacity and increased their apoptosis. These changes in platelet glycoside residues appeared to be related to ITP severity.Entities:
Keywords: glycoside residues; immune thrombocytopaenia; platelet activation markers; platelet apoptosis; sialic acid
Year: 2021 PMID: 33924503 DOI: 10.3390/jcm10081661
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241